Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 301–320 of 17,898 drug recalls

Drug Recall Ongoing 2026 recordClass II

MGC Health, Menthol- Cough Suppressant, Oral Anesthetic, Cough Drops, Honey Lemon, 80-count bag, Distributed By: Medical Group Care, LLC, 1035 Collier Center Way, STE 5, Naples, FL 34110, NDC: 83698-114-80, UPC: 383173000030.

by Xiamen Kang Zhongyuan Biotechnology Co., Ltd.

Reason
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
Recall initiated
March 20, 2026
Reported by FDA
April 22, 2026
Distribution
US Nationwide.

View recall →

Drug Recall Ongoing 2026 recordClass II

MGC Health, Menthol- Cough Suppressant, Oral Anesthetic, Cough Drops, Honey Lemon, 30-count bag, Distributed By: Medical Group Care, LLC, 1035 Collier Center Way, STE 5, Naples, FL 34110, NDC: 83698-114-30, UPC: 383173000047.

by Xiamen Kang Zhongyuan Biotechnology Co., Ltd.

Reason
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
Recall initiated
March 20, 2026
Reported by FDA
April 22, 2026
Distribution
US Nationwide.

View recall →

Drug Recall Ongoing 2026 recordClass II

MGC Health, Menthol- Cough Suppressant, Oral Anesthetic, Cough Drops, Sugar Free, Honey Lemon, 25-count bag, Distributed By: Medical Group Care, LLC, 1035 Collier Center Way, STE 5, Naples, FL 34110, NDC: 83698-125-25, UPC: 383173000085

by Xiamen Kang Zhongyuan Biotechnology Co., Ltd.

Reason
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
Recall initiated
March 20, 2026
Reported by FDA
April 22, 2026
Distribution
US Nationwide.

View recall →

Drug Recall Ongoing 2026 recordClass II

Discount Drug Mart Food Market, Cough Drops, Menthol -Cough Suppressant Anesthetic, 30-count bag, Distributed By: Drug Mart-Food Fair, Medina, Ohio 44256, Made in China, NDC: 83698-102-30, UPC: 093351037085.

by Xiamen Kang Zhongyuan Biotechnology Co., Ltd.

Reason
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
Recall initiated
March 20, 2026
Reported by FDA
April 22, 2026
Distribution
US Nationwide.

View recall →

Drug Recall Ongoing 2026 recordClass II

Discount Drug Mart Food Market, Cough Drops, Menthol- Cough Suppressant Anesthetic, Honey Lemon, 30-count bag, Distributed By: Drug Mart-Food Fair, Medina, Ohio, 44256, Made in China, NDC: 83698-150-30, UPC: 093351037092.

by Xiamen Kang Zhongyuan Biotechnology Co., Ltd.

Reason
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
Recall initiated
March 20, 2026
Reported by FDA
April 22, 2026
Distribution
US Nationwide.

View recall →

Drug Recall Ongoing 2026 recordClass II

caring mill, Menthol Cough Suppressant Oral Anesthetic, Cough Drops, Cherry, 90-count bag, Distributed by: FSA Store Inc., 5473 Blair Rd, Suite 100, PMB 24308, Dallas TX 75231, Made in China, NDC: 83698-421-90, UPC: 810025928407.

by Xiamen Kang Zhongyuan Biotechnology Co., Ltd.

Reason
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
Recall initiated
March 20, 2026
Reported by FDA
April 22, 2026
Distribution
US Nationwide.

View recall →

Drug Recall Ongoing 2026 recordClass II

exchange select, Menthol- Cough Suppressant Oral Anesthetic, Cough Drops, Menthol Flavor, 30-count bag, Manufactured for Your Military Exchanges By: Medical Group Care, LLC, 1035 Collier Center Way, STE 5, Naples, FL, Made in China, NDC: 83698-581-30, UPC: 614299398887.

by Xiamen Kang Zhongyuan Biotechnology Co., Ltd.

Reason
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
Recall initiated
March 20, 2026
Reported by FDA
April 22, 2026
Distribution
US Nationwide.

View recall →

Drug Recall Ongoing 2026 recordClass II

exchange select, Menthol -Cough Suppressant Oral Anesthetic, Honey Lemon Flavor Cough Drops, 30-count bag, Manufactured for Your Military Exchanges By: Medical Group Care, LLC., 1035 Collier Center Way, STE 5, Naples, FL, Made in China, NDC 83698-580-30, UPC: 614299398870.

by Xiamen Kang Zhongyuan Biotechnology Co., Ltd.

Reason
This recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility that may bear on product quality.
Recall initiated
March 20, 2026
Reported by FDA
April 22, 2026
Distribution
US Nationwide.

View recall →

Drug Recall Ongoing 2026 recordClass II

SLMD Benzoyl Peroxide Acne Lotion, Benzoyl Peroxide 2.5%, a) 0.7 fl. oz - 21 mL and b) 1.5 fl. oz. - 44mL bottles, SANDRA LEE MD., Distributed by Skin PS Brands, Culver City, CA 90232.

by Owen Biosciences Inc.

Reason
Chemical contamination: Presence of benzene
Recall initiated
March 3, 2026
Reported by FDA
April 22, 2026
Distribution
U.S. Nationwide

View recall →

Drug Recall Ongoing 2026 recordClass II

SLMD BP Acne Spot Treatment, 10% Benzoyl Peroxide, 0.5 fl. oz - 15 mL bottles, Sandra Lee MD, Distributed by Skin PS Brands, Culver City, CA90232.

by Owen Biosciences Inc.

Reason
Chemical contamination: Presence of benzene
Recall initiated
March 3, 2026
Reported by FDA
April 22, 2026
Distribution
U.S. Nationwide

View recall →

Drug Recall Ongoing 2026 recordClass II

HydroPeptide CLEAR ALLIANCE SERUM, 2.5% BENZOYL PEROXIDE, a)1 FL OZ/30ml; b) 2 FL OZ/60ml spray bottle; DIST BY HYDROPEPTIDE LLC, ISSAQUAH, WA 98027

by Owen Biosciences Inc.

Reason
Chemical contamination: Presence of benzene
Recall initiated
March 3, 2026
Reported by FDA
April 22, 2026
Distribution
U.S. Nationwide

View recall →

Drug Recall Ongoing 2026 recordClass II

FHF Farmhouse Fresh, Midnight Clearing, NIGHT LOTION, 2.5% BENZOYL PEROXIDE ACNE TREATMENT, OTC a) 0.5 fl. oz./15ml; and b)1 fl. oz./30ml tubes; Made in the USA for FarmHouse Fresh, 8797 CR 858 McKinney, Texas

by Owen Biosciences Inc.

Reason
Chemical contamination: Presence of benzene
Recall initiated
March 3, 2026
Reported by FDA
April 22, 2026
Distribution
U.S. Nationwide

View recall →

Drug Recall Ongoing 2026 recordClass II

Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-412-02

by Cipla USA, Inc.

Reason
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
Recall initiated
March 16, 2026
Reported by FDA
April 22, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Cinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-411-02

by Cipla USA, Inc.

Reason
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
Recall initiated
March 16, 2026
Reported by FDA
April 22, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-410-02

by Cipla USA, Inc.

Reason
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
Recall initiated
March 16, 2026
Reported by FDA
April 22, 2026
Distribution
Nationwide in the USA

View recall →

Drug Recall Ongoing 2026 recordClass II

Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3510-04 carton, NDC 0591-3510-54 pouch

by Teva Pharmaceuticals USA, Inc

Reason
CGMP Deviations: use of an unapproved raw material
Recall initiated
March 19, 2026
Reported by FDA
April 15, 2026
Distribution
Within U.S

View recall →

Drug Recall Ongoing 2026 recordClass II

Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3509-04 carton, NDC 0591-3509-54 pouch

by Teva Pharmaceuticals USA, Inc

Reason
CGMP Deviations: use of an unapproved raw material
Recall initiated
March 19, 2026
Reported by FDA
April 15, 2026
Distribution
Within U.S

View recall →

Drug Recall Ongoing 2026 recordClass II

Clonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx Only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc, Parsippany, NJ, NDC 0591-3508-04 carton, NDC 0591-3508-54 pouch

by Teva Pharmaceuticals USA, Inc

Reason
CGMP Deviations: use of an unapproved raw material
Recall initiated
March 19, 2026
Reported by FDA
April 15, 2026
Distribution
Within U.S

View recall →

Drug Recall Ongoing 2026 recordClass II

GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1414-91.

by GE Healthcare Ireland Limited

Reason
Presence of particulate matter
Recall initiated
March 24, 2026
Reported by FDA
April 15, 2026
Distribution
U.S. Nationwide.

View recall →

Drug Recall Ongoing 2026 recordClass II

GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1413-63.

by GE Healthcare Ireland Limited

Reason
Presence of particulate matter
Recall initiated
March 24, 2026
Reported by FDA
April 15, 2026
Distribution
U.S. Nationwide.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.